Article Text

PDF
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C
  1. U Arena1,
  2. F Vizzutti1,
  3. J G Abraldes2,
  4. G Corti3,
  5. C Stasi3,
  6. S Moscarella1,
  7. S Milani4,5,
  8. E Lorefice4,
  9. A Petrarca1,
  10. R G Romanelli1,
  11. G Laffi1,
  12. J Bosch2,
  13. F Marra1,5,
  14. M Pinzani1,5
  1. 1
    Department of Internal Medicine, University of Firenze, Firenze, Italy
  2. 2
    Hepatic Hemodynamic Laboratory, Hospital Clinic, University of Barcelona, Barcelona, Spain
  3. 3
    Unit for Infective and Tropical Diseases, University of Firenze, Firenze, Italy
  4. 4
    Department of Clinical Pathophysiology, University of Firenze, Firenze, Italy
  5. 5
    Center for Research, Higher Education and Transfer DENOThE, University of Firenze, Firenze, Italy
  1. Professor M Pinzani, Dipartimento di Medicina Interna, Viale G.B. Morgagni, 85, 50134 Firenze, Italy; m.pinzani{at}dmi.unifi.it

Abstract

Background: Transient elastography (TE) has received increasing attention as a means to evaluate disease progression in patients with chronic liver disease.

Aim: To assess the value of TE for predicting the stage of fibrosis.

Methods: Liver biopsy and TE were performed in 150 consecutive patients with chronic hepatitis C-related hepatitis (92 men and 58 women, age 50.6 (SD 12.5) years on the same day. Necro-inflammatory activity and the degree of steatosis at biopsy were also evaluated.

Results: The areas under the curve for the prediction of significant fibrosis (⩾F2), advanced fibrosis (⩾F3) or cirrhosis were 0.91, 0.99 and 0.98, respectively. Calculation of multilevel likelihood ratios showed that values of TE <6 or ⩾12, <9 or ⩾12, and <12 or ⩾18, clearly indicated the absence or presence of significant fibrosis, advanced fibrosis, and cirrhosis, respectively. Intermediate values could not be reliably associated with the absence or presence of the target condition. The presence of inflammation significantly affected TE measurements in patients who did not have cirrhosis (p<0.0001), even after adjusting for the stage of fibrosis. Importantly, TE measurements were not influenced by the degree of steatosis.

Conclusions: TE is more suitable for the identification of patients with advanced fibrosis than of those with cirrhosis or significant fibrosis. In patients in whom likelihood ratios are not optimal and do not provide a reliable indication of the disease stage, liver biopsy should be considered when clinically indicated. Necro-inflammatory activity, but not steatosis, strongly and independently influences TE measurement in patients who do not have cirrhosis.

Statistics from Altmetric.com

Footnotes

  • UA and FV contributed equally to this study.

  • Funding: This work was funded by grants from the Italian MIUR, the University of Florence and the Italian Liver Foundation and Instituto de Salud Carlos III, Spain (FIS 05/0519 and FIS 06/0623).

  • Competing interests: None declared.

  • Ethics approval: The study protocol was approved by the Investigation and Ethics Committee of the Azienda Ospedaliero Universitaria di Careggi, Firenze, on 4 September 2006.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Digest
    Robin Spiller Magnus Simren